Press Release – New York, NY – October 12, 2026 – Sichenzia Ross Ference Carmel LLP announced today that it represented Sunshine Biopharma Inc. (NASDAQ: SBFM), a pharmaceutical company specializing in generic and specialty prescription medications, including drugs in the areas of oncology and antivirals, in its recent public offering of up to $20.4 million.
The SRFC team was led by partners Gregory Sichenzia and Jeff Cahlon, with counsel Scot Foley and associate Benasz Hansotia.